quinazolines has been researched along with Proteinuria in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Advani, A; Advani, SL; Connelly, KA; Gilbert, RE; Kelly, DJ; Thai, K; Zhang, Y | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Liu, C; Wang, Y; Wei, P; Zhang, H; Zhang, L | 1 |
| Berlin, ST; Humphreys, BD; Ivy, P; Matulonis, UA; Penson, RT; Robinson, ES; Tyburski, K | 1 |
| Bou Matar, RN; Klein, JD; Sands, JM | 1 |
| Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL | 1 |
| Armand, JP; Mir, O; Ropert, S | 1 |
| Hodge, JV; Lubbe, WF | 1 |
| Dousa, TP; Grande, JP; Johnson, RJ; Shankland, SJ; Tsuboi, Y; Walker, HJ | 1 |
1 review(s) available for quinazolines and Proteinuria
| Article | Year |
|---|---|
[Oral drugs inhibiting the VEGF pathway].
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Asthenia; Axitinib; Benzenesulfonates; Humans; Hypertension; Imidazoles; Indazoles; Indoles; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phthalazines; Piperidines; Proteinuria; Pyridines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A | 2007 |
1 trial(s) available for quinazolines and Proteinuria
| Article | Year |
|---|---|
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antineoplastic Agents; Blood Pressure; Carcinoma; Chi-Square Distribution; Female; Humans; Hypertension; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
7 other study(ies) available for quinazolines and Proteinuria
| Article | Year |
|---|---|
Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetes.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Hypertension; Kidney; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Piperidines; Proteinuria; Quinazolines; Rats; Receptors, Vascular Endothelial Growth Factor; Systole | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Inhibition of PI3Kδ improves systemic lupus in mice.
Topics: Adenine; Animals; Antibodies, Antinuclear; Chemokine CCL2; Class I Phosphatidylinositol 3-Kinases; Creatinine; Interleukin-17; Interleukin-1beta; Kidney; Kidney Function Tests; Liver; Lupus Erythematosus, Systemic; Male; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proteinuria; Proto-Oncogene Proteins c-akt; Quinazolines | 2014 |
Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
Topics: Animals; Antibiotics, Antineoplastic; Aquaporin 2; Creatinine; Doxorubicin; Epithelial Sodium Channels; ErbB Receptors; Erlotinib Hydrochloride; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Male; Nephrotic Syndrome; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Rats; Renal Insufficiency; Sodium Chloride Symporters; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1 | 2013 |
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley | 2004 |
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Oxprenolol; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Quinazolines | 1981 |
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Animals; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Glomerulonephritis, Membranoproliferative; Hydralazine; Isoenzymes; Kidney Function Tests; Kidney Glomerulus; Laminin; Male; Phosphodiesterase Inhibitors; Proteinuria; Pyrrolidinones; Quinazolines; Rats; Rats, Wistar; Rolipram; Superoxides | 1996 |